Who Paid My Doc
Lipiflow System Activator (Disposable)
Device
PDI 00859623006216
General payments
$333,918
Research payments
$335,521
Through program year 2025, $333,918 in general payments and $335,521 in research payments were reported against Lipiflow System Activator (Disposable).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
9 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $32,780 | 175 |
| 2024 | General | $34,206 | 171 |
| 2024 | Research | $55,000 | 3 |
| 2023 | General | $70,020 | 554 |
| 2023 | Research | $64,500 | 2 |
| 2022 | General | $158,864 | 679 |
| 2022 | Research | $76,705 | 5 |
| 2021 | General | $38,049 | 515 |
| 2021 | Research | $139,316 | 10 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 6 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 21 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
2,094 general · 20 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.